群星品牌怎么样 申请店铺

我要投票 群星在中草药行业中的票数:79 更新时间:2025-02-06
群星是哪个国家的品牌?「群星」是 广州白云山医药集团股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人李楚源在1997-09-01期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
群星怎么样

广州白云山星群(药业)股份有限公司是广药集团属下上市公司广州药业(香港H股及上海A股上市公司)骨干企业之一,经过半个多世纪的持续创新发展,公司现已发展成一家以胶丸、酊水糖浆、药油、颗粒冲剂四个剂型为主,拥有600余名员工,年销售近4亿元、利税逾8000万元的制药企业。

建厂初期二天堂、同仁等多家制油药厂的加盟,使星群传承不少“经典配方”,改进或研发的二天油、通窍救心油、红花油等众多药油产品,使星群成为名副其实的“药油世家”。

60年代末,星群成功研制出颗粒冲剂;1985年首创夏桑菊颗粒,并带动颗粒产品进入繁荣时代;为广大消费者熟知的颗粒冲剂还有小儿氨酚黄那敏、痔炎消等。

星群生产酊水糖浆、口服液也有悠久历史,产品有安神补脑液、复方甘草口服溶液等。如今星群已发展为拥有九高剂型近100多个优质产品的制药企业。

星群人始终以“超越自我,追求卓越”的企业精神构建优秀的企业文化,现拥有包括博士、硕士、执业药师及具备高、中职称的各类专业技术人员230多人。

近年,企业引进了多套具有国际专业水平的颗粒、软胶囊、液体灌装制造及包装设备,注重按GMP规范(药品生产质量管理规范)进行生产和质量管理,各剂型均通过GMP认证,建有大型夏枯草GAP药材种植基地;同时以科技创新推动品牌发展,启动夏桑菊“指纹图谱”技术评价产品质量及开展夏桑菊有效部位抗禽流感、流感项目研究,并获授专利保护。

Guangzhou Baiyunshan Xingqun (pharmaceutical) Co., Ltd. is one of the backbone enterprises of Guangzhou Pharmaceutical (Hong Kong H-share and Shanghai A-share listed companies), a listed company under Guangzhou Pharmaceutical Group. After more than half a century of continuous innovation and development, the company has developed into a four dosage forms mainly including gel pills, tincture water syrup, pharmaceutical oil and granule granules, with more than 600 employees and annual sales of nearly 400 million yuan and profit Pharmaceutical enterprises with tax over 80 million yuan. At the early stage of the establishment of the plant, the alliance of several oil-making pharmaceutical factories, such as ertiantang and Tongren, made Star Group inherit many "classic formulas", improved or developed many pharmaceutical oil products, such as Ertianyou, tongqiaojiuxinyou, safflower oil, etc., which made Star Group become a veritable "pharmaceutical oil family". In the late 1960s, Xingqun successfully developed granule granules; in 1985, Xiasangju granules were first created, which led the granule products to enter a prosperous era; the granule granules well known to consumers include Xiaoer aminophenol huangnamin, Zhiyanxiao, etc. Star Group has a long history in producing tincture water syrup and oral liquid. Its products include Anshen Bunao liquid, Compound Glycyrrhiza Oral Solution, etc. Now, Xingqun has developed into a pharmaceutical enterprise with more than 100 high-quality products of nine high dosage forms. Xingqun people always build excellent corporate culture with the enterprise spirit of "surpassing oneself and pursuing excellence". Now it has more than 230 professional and technical personnel including doctors, masters, licensed pharmacists and high and medium professional titles. In recent years, the company has introduced a number of sets of international professional granule, soft capsule, liquid filling and packaging equipment, focusing on production and quality management in accordance with GMP (drug production quality management specification), all dosage forms have passed GMP certification, and has established a large-scale Prunella vulgaris gap drug planting base; at the same time, it promotes the brand development with scientific and technological innovation, and starts the "fingerprint" technology of summer mulberry To evaluate the product quality and carry out the research on the anti avian influenza and influenza project of effective parts of chamomile, and to be granted patent protection.

本文链接: https://brand.waitui.com/9d7b6889d.html 联系电话:02066281011

千城特选小程序码

7×24h 快讯

美股大型科技股盘前多数下跌,谷歌跌超7%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,谷歌跌超7%,亚马逊、苹果跌超1%,特斯拉跌0.92%,微软跌0.36%,Meta跌0.35%,奈飞跌0.14%;英伟达涨近1%。

2小时前

热门中概股美股盘前多数走弱,拼多多跌超7%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,拼多多跌超7%,理想汽车、微博跌超3%,阿里巴巴、京东、百度、蔚来跌超2%,小鹏汽车、爱奇艺跌超1%;B站涨超1%。

2小时前

君实生物:AWT020注射用无菌粉末临床试验申请获批

36氪获悉,君实生物公告,近日,公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,AWT020注射用无菌粉末(项目代号“JS213”)的临床试验申请获得批准。JS213是PD-1和白细胞介素-2双功能性抗体融合蛋白,主要用于晚期恶性肿瘤的治疗。

2小时前

渣打集团任命Maria Ramos接替韦浩思担任集团主席

2月4日,渣打集团董事会宣布,鉴于韦浩思(José Viñals)已接近他服务满9年的任期,已任命Maria Ramos(65岁)接替韦浩思担任集团主席。待取得监管批准后,Maria将于公司在2025年5月8日举行的2025年股东周年大会后履新,而韦浩思届时将自董事会退任。(界面)

2小时前

三六零:公司暂未向DeepSeek提供任何服务

36氪获悉,三六零公告,公司股票于2025年1月24日、1月27日、2月5日连续三个交易日内收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。经自查,公司注意到相关平台将公司股票纳入DeepSeek概念股。公司就相关事项澄清说明如下:在DeepSeek基于MIT开源协议的生态环境下,公司旗下的部分产品进行了DeepSeek的接入与本地化部署;公司暂未向DeepSeek提供任何服务。除上述事项外,公司未发现其他可能对公司股票交易价格产生较大影响的、需要公司澄清或回应的媒体报道或市场传闻

2小时前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询